or Try an Advanced Search...

    Molecule Therapeutics Stocks List

    Symbol Grade Name % Change
    KZR B Kezar Life Sciences, Inc. 1.20
    MNOV C MediciNova, Inc. 3.74
    CYTK D Cytokinetics, Incorporated -3.22
    ZNTL D Zentalis Pharmaceuticals, Inc. 2.84
    ARDX F Ardelyx, Inc. 4.26
    ENTX F Entera Bio Ltd. 5.16
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Biotechnology Cancer Clinical Development Hormones Amyotrophic Lateral Sclerosis Antiestrogens Asthma Autoimmunity Breast Cancer Bronchial Asthma Central Nervous System Disorders Chronic Kidney Disease Constipation Cytokine Disease Drug Design Drugs Dysfunction End Stage Renal Disease

    Related ETFs - A few ETFs which own one or more of the above listed Molecule Therapeutics stocks.

    Symbol Grade Name Weight
    SURI C Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 3.93
    HRTS D Tema Cardiovascular and Metabolic ETF 3.47
    XBI D SPDR S&P Biotech ETF 2.26
    LABU F Direxion Daily S&P Biotech Bull 3X Shares 1.45
    CNCR F Loncar Cancer Immunotherapy ETF 1.25
    View all Molecule Therapeutics ETFs...
    Compare ETFs
    Compare HRTS to XBI Compare LABU to CNCR Compare SURI to HRTS

        Molecule Therapeutics Stocks Recent News

        Date Stock Title
        Nov 20 CYTK Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
        Nov 20 ARDX Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
        Nov 19 ARDX High Growth Tech Stocks To Explore In November 2024
        Nov 19 CYTK Cytokinetics and Bayer partner to develop for aficamten in Japan
        Nov 19 CYTK Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
        Nov 19 CYTK Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan
        Nov 19 CYTK Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan
        Nov 19 CYTK Bayer acquires rights to Cytokinetics' heart drug in Japan
        Nov 19 CYTK Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
        Nov 18 ARDX US Penny Stocks To Monitor In November 2024
        Nov 16 CYTK Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
        Nov 16 CYTK Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Biotechnology Cancer Clinical Development Hormones Amyotrophic Lateral Sclerosis Antiestrogens Asthma Autoimmunity Breast Cancer Bronchial Asthma Central Nervous System Disorders Chronic Kidney Disease Constipation Cytokine Disease Drug Design Drugs Dysfunction End Stage Renal Disease
        Molecule Therapeutics

        Molecule Therapeutics is a branch of biotechnology that focuses on the development of therapeutic molecules for the treatment of diseases. This includes the development of small molecules, peptides, proteins, and nucleic acids for therapeutic use. Molecule Therapeutics also involves the study of the structure and function of molecules, as well as the development of new methods for drug delivery.

        Browse All Tags